EUVIMEDEUVIMED entdecken
Crossref

Plozasiran, an RNA interference agent targeting APOC3, for mixed hyperlipidemia

Ballantyne C.M.

Yearbook of Paediatric Endocrinology · 30.09.2025

DOI: 10.1530/ey.22.12.11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von Ballantyne C.M..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

C.M., B. (2025). Plozasiran, an RNA interference agent targeting APOC3, for mixed hyperlipidemia. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.12.11

Vancouver

C.M. B. Plozasiran, an RNA interference agent targeting APOC3, for mixed hyperlipidemia. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.12.11

BibTeX
@article{CM2025,
  author = {C.M., Ballantyne},
  title = {Plozasiran, an RNA interference agent targeting APOC3, for mixed hyperlipidemia},
  journal = {Yearbook of Paediatric Endocrinology},
  year = {2025},
  doi = {10.1530/ey.22.12.11}
}
Kostenlos starten →